Chemoinformaics analysis of 1-(Cyclohex-1-en-1-yl)piperidine
Molecular Weight | 165.28 | nRot | 1 |
Heavy Atom Molecular Weight | 146.128 | nRig | 12 |
Exact Molecular Weight | 165.152 | nRing | 2 |
Solubility: LogS | -3.014 | nHRing | 1 |
Solubility: LogP | 3.215 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 11 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 32.1391 |
nHD | 0 | BPOL | 20.7709 |
QED | 0.577 |
Synth | 2.392 |
Natural Product Likeliness | -0.407 |
NR-PPAR-gamma | 0.01 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.284 |
Pgp-sub | 0.013 |
HIA | 0.006 |
CACO-2 | -4.642 |
MDCK | 0.0000138 |
BBB | 0.936 |
PPB | 0.843248 |
VDSS | 1.082 |
FU | 0.247615 |
CYP1A2-inh | 0.696 |
CYP1A2-sub | 0.928 |
CYP2c19-inh | 0.454 |
CYP2c19-sub | 0.406 |
CYP2c9-inh | 0.15 |
CYP2c9-sub | 0.633 |
CYP2d6-inh | 0.185 |
CYP2d6-sub | 0.863 |
CYP3a4-inh | 0.153 |
CYP3a4-sub | 0.197 |
CL | 7.504 |
T12 | 0.554 |
hERG | 0.062 |
Ames | 0.008 |
ROA | 0.065 |
SkinSen | 0.96 |
Carcinogencity | 0.528 |
EI | 0.973 |
Respiratory | 0.954 |
NR-Aromatase | 0.099 |
Antiviral | No |
Prediction | 0.771397 |